Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study.
Morgan E, Suresh A, Ganju A, Stover DG, Wesolowski R, Sardesai S, Noonan A, Reinbolt R, VanDeusen J, Williams N, Cherian MA, Li Z, Young G, Palettas M, Stephens J, Liu J, Luff A, Ramaswamy B, Lustberg M. Morgan E, et al. Among authors: ganju a. World J Surg Oncol. 2020 Jan 14;18(1):11. doi: 10.1186/s12957-019-1780-8. World J Surg Oncol. 2020. PMID: 31937323 Free PMC article.
Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female Controls.
Liu J, Suresh A, Palettas M, Stephens J, Ganju A, Morgan E, Kassem M, Hou Y, Parwani A, Noonan A, Reinbolt R, VanDeusen J, Sardesai S, Williams N, Cherian M, Tozbikian G, Stover DG, Lustberg M, Li Z, Ramaswamy B, Wesolowski R. Liu J, et al. Among authors: ganju a. Eur J Breast Health. 2020 May 20;16(3):201-207. doi: 10.5152/ejbh.2020.5536. eCollection 2020 Jul. Eur J Breast Health. 2020. PMID: 32656521 Free PMC article.
MicroRNA dysregulation in melanoma.
Latchana N, Ganju A, Howard JH, Carson WE 3rd. Latchana N, et al. Among authors: ganju a. Surg Oncol. 2016 Sep;25(3):184-9. doi: 10.1016/j.suronc.2016.05.017. Epub 2016 May 20. Surg Oncol. 2016. PMID: 27566021 Review.
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.
McMichael EL, Benner B, Atwal LS, Courtney NB, Mo X, Davis ME, Campbell AR, Duggan MC, Williams K, Martin K, Levine K, Olaverria Salavaggione GN, Noel T, Ganju A, Uppati S, Paul B, Olencki T, Teknos TN, Savvides P, Tridandapani S, Byrd JC, Caligiuri MA, Liu SV, Carson WE 3rd. McMichael EL, et al. Among authors: ganju a. Clin Cancer Res. 2019 Aug 15;25(16):4955-4965. doi: 10.1158/1078-0432.CCR-18-2108. Epub 2019 May 29. Clin Cancer Res. 2019. PMID: 31142501 Free PMC article. Clinical Trial.
MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor.
Martin del Campo SE, Latchana N, Levine KM, Grignol VP, Fairchild ET, Jaime-Ramirez AC, Dao TV, Karpa VI, Carson M, Ganju A, Chan AN, Carson WE 3rd. Martin del Campo SE, et al. Among authors: ganju a. PLoS One. 2015 Jan 14;10(1):e0115919. doi: 10.1371/journal.pone.0115919. eCollection 2015. PLoS One. 2015. PMID: 25587717 Free PMC article.
105 results